(Q33361984)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15291352%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Rituximab followed by cladribine in the treatment of heavily pretreated patients with indolent lymphoid malignancies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15291352%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15291352%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1

Tadeusz Robak

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15291352%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

2

Piotr Smolewski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15291352%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

6

Marek Kasznicki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15291352%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

5

Jerzy Z Blonski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15291352%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

3

Halina Urbanska-Rys

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15291352%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 May 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15291352%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15291352%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15291352%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15291352%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

937-944

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15291352%20AND%20SRC:MED&resulttype=core&format=json

Anti-CD20-based therapy of B cell lymphoma: state of the art.

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159825

Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159825

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159825

Antibody-based therapy of non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159825

Rituximab plus chemotherapy in follicular and mantle cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819032000159825

10.1080/1042819032000159825

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15291352%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference